1.0cemkahttps://www.cemka.fr/en/rich600338<blockquote class="wp-embedded-content" data-secret="rVhGmMuqoH"><a href="https://www.cemka.fr/en/intervenants/prunelle-gaugy/">Prunelle GAUGY</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cemka.fr/en/intervenants/prunelle-gaugy/embed/#?secret=rVhGmMuqoH" width="600" height="338" title="“Prunelle GAUGY” — cemka" data-secret="rVhGmMuqoH" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cemka.fr/wp-includes/js/wp-embed.min.js </script> https://www.cemka.fr/wp-content/uploads/2019/07/DSC_14_prunelle-scaled.jpg13652048Prunelle GAUGY is Director of Market Access & Pricing at CEMKA. She supports pharmaceutical, biotech and medical device companies in defining and implementing market access, pricing and reimbursement strategies throughout the product lifecycle. Since joining CEMKA in 2018, she has contributed to the launch and market access of numerous healthcare products across a wide range of therapeutic areas, including oncology, […]